Login / Signup

Evaluating the diagnostic and prognostic value of biomarkers for heart disease and major adverse cardiac events in patients with muscular dystrophy.

Anish NikhanjBailey Miskew NicholsKaiming WangZaeem A SiddiqiGavin Y Oudit
Published in: European heart journal. Quality of care & clinical outcomes (2022)
Our study demonstrates important diagnostic and prognostic value of BNP and hsTnI as part of a comprehensive cardiac assessment to augment the management and treatment of heart disease in patients with MD.
Keyphrases
  • muscular dystrophy
  • pulmonary hypertension
  • left ventricular
  • duchenne muscular dystrophy
  • molecular dynamics
  • emergency department
  • heart failure